-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...
More »SEARCH RESULT
Total Matching Records found : 21
Reality behind Odisha’s dying infants -Vidya Krishnan
-The Hindu What happened at Shishubhawan is symptomatic of how deep the rot is in India's crumbling public health infrastructure. It has been two months since news and reports of the deaths of 40 infants at Shishubhawan, the largest paediatric care centre in eastern India, broke. The facility is for critically-ill children from Jharkhand, Chhattisgarh and Odisha. By the end of September, 56 deaths were reported in a span on 12 days. Even...
More »Narendra Modi govt cracks down on NGOs, prepares hitlist -Sanjib Kr Baruah and Rajesh Ahuja
-The Hindustan Times The Centre may act against some of the 188 NGOs red-flagged by the Intelligence Bureau for alleged misuse of foreign funds, suspected extremist links and proselytization. These non-government organisations were reported by the internal spy agency and a list sent to the home ministry, documents accessed by HT have revealed. The country's top tax body the central board of direct taxes (CBDT) and enforcement directorate (ED), which tracks foreign funds...
More »Disaster in progress -Indira Jaising
-The Indian Express On the 30th anniversary of the Bhopal disaster, memories of the victims' suffering surface once again. One is at a loss for words to describe what happened on the intervening night of December 2-3, 1984. Was it an accident? Or was it industrial genocide? We will never know what it was, since no investigation was conducted on what caused water to leak into 41 tonnes of higly toxic...
More »Outside the patent monopolies -Ritu Kamal
-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...
More »
